Oxford Covid vaccine trials to start at King Edward hospital
NEW DELHI [Maha Media]: The King Edward memorial Hospital in Parel, Mumbai will soon start phase 2 and 3 human trials on COVISHIELD, the Covid vaccine that is being developed by Oxford University and AstraZenec. India is among the handful of countries where human trials for this vaccine will be carried out, outside of the UK.
Speaking to India Today TV, Dr Hemant Deshmukh, Dean, KEM Hospital said the phase 2 and 3 human trials of COVISHIELD will start by the end of August.
COVISHIELD hogged global headlines in July after it showed "promising "and "encouraging" results in Phase 1 human trials conducted in the UK. The data for these trials were published in The Lancet.
In the latest, the Indian Council for Medical Research (ICMR) has granted approval to Mumbai's King Edward Memorial Hospital in Parel to conduct phase 2 and 3 clinical trials of the Oxford University's coronavirus vaccine.
Dr Deshmukh said the hospital has started enrolling people for the trials.
According to King Edward Memorial Hospital, a total of 160 healthy people in Mumbai will take part in the phase 2 and 3 human trials of COVISHIELD, the vaccine developed by Oxford University and AstraZenec.
The trials are likely to commence by end of this month.